Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 167
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Psychedelic Bulletin #110 – Psychedelics Docuseries Comes to Netflix; DEA Schedules...
FILAMENT HEALTH ANNOUNCES FIRST DOSING IN GROUNDBREAKING FDA-APPROVED PSILOCIN CLINICAL TRIAL
PT335 – Christopher Dawson & Andrew Galloway – Modernizing Traditional Plant...
Tripping the Reward Circuit: Psychedelics for Substance Use Disorders
Psychedelic Drugs Market Reaches US$6330.0 Mn by 2026 from US$3210.0 Mn...
Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study
Numinus to Host Q3 2022 Results Conference Call on July 14,...
Algernon Pharmaceuticals Discloses Novel DMT Salt Patent Strategy Includes Bioactive Nicotinate...
FILAMENT HEALTH ANNOUNCES SIXTH PATENT ISSUANCE
Mindset Pharma Receives Allowance for Patent Application Covering its Short-Duration Novel...
Load more
